Vikas Jain, MD
Sleep Medicine · Frisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
Offices
2 locations · Jig International LLC · Coryell County Memorial Hospital Authority
Hospitals listed: Baylor Medical Center at Frisco · Coryell Memorial Hospital. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Jain’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A115489 · Current
Licensed to practise in California · since 2011 · expires 2028-08-31 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
2 licences
- Illinois 036140333Licensed Physician And Surgeon · since 2016 · expires 2029-07-31ActiveNo board action on this licenceCheck it with the state
- Texas R7027Physician License · since 2018 · expires 2027-05-31ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Baylor Scott & White Medical Center - FriscoFrisco, TXAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
- Coryell Memorial HospitalGatesville, TXCritical Access Hospital · Government - Hospital District or Authority · Has an emergency departmentPatients rate it 5 of 5 · 82% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for Baylor Scott & White Medical Center - Frisco
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Safety: 1 better, 3 the same, 0 worse of 4 measures. Readmissions: 0 better, 4 the same, 0 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.07) · 164 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.11 (0.62 to 1.6) | No different | Jul 2022 – Jun 2024 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 235 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 417 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 399 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.05 (1.55 to 6.54) · 348 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.3) · 305 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.82 (1.14 to 4.5) · 335 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.68 (2.74 to 20.62) · 319 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.43 (2.3 to 10.55) · 270 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.23 to 3.28) · 100 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.59 (0 to 1.9) · 128 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 67 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.321 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.502 | No different | Oct 2024 – Sep 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.8 · 63 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.1 (10.6 to 18.6) · 815 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 496 cases | No different | Jan 2024 – Dec 2024 |
What patients said (247 patients answered, 10% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 91% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 68% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Coryell Memorial Hospital
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for pneumonia patientsComplications and deaths | 20 · 71 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.1 · 34 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 327 cases | None | Jul 2024 – Jun 2025 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 71 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 1.093 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 50 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 3.2 · 71 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.8 · 115 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.9 · 62 cases | None | Jul 2023 – Jun 2025 |
What patients said (133 patients answered, 27% of those asked)
| Cleanliness | 3 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 5 |
| Overall hospital rating | 5 |
| Quietness | 5 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 84% |
| Doctors "always" communicated well | 86% |
| Staff "always" explained | 68% |
| Yes, staff "did" give patients this information | 91% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 84% |
| Doctors "always" listened carefully | 85% |
| Doctors "always" treated them with courtesy and respect | 90% |
| Patients who gave a rating of "9" or "10" (high) | 81% |
| Staff "always" explained new medications | 80% |
| Nurses "always" explained things so they could understand | 83% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 74% |
| "YES", patients would definitely recommend the hospital | 82% |
| Staff "always" explained possible side effects | 56% |
| Yes, staff "did" give patients information about possible symptoms | 95% |
Original Medicare doctor bills
$184,524
Medicare paid this office $184,524 for 587 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 518 | $86,244 | $89 |
| Sleep study including heart rate, breathing, and sleep time | 213 | $44,092 | $96 |
| New patient visit (45+ min) | 257 | $28,645 | $111 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 83 | $11,311 | $35 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 308 | $5,529 | $12 |
See all 9 services
| Return visit (30+ min) | 518 | $86,244 | $89 |
| Sleep study including heart rate, breathing, and sleep time | 213 | $44,092 | $96 |
| New patient visit (45+ min) | 257 | $28,645 | $111 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 83 | $11,311 | $35 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 308 | $5,529 | $12 |
| Long return visit (40+ min) | 15 | $4,621 | $132 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 12 | $1,354 | $80 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 87 | $1,288 | $15 |
| Sleep study in sleep lab (6 years or older) | 12 | $1,065 | $89 |
Who their Medicare patients are
587 Original Medicare patients in 2024. Average age 73 · Under 65 3% · 85 and older 4% · Women 43% · Health risk score 0.91. At or below the middle of the specialty; the typical sleep medicine clinician is at 1.21.
Conditions among them: High blood pressure 75% · Diabetes 31% · Coronary heart disease 30% · Depression 24% · Chronic kidney disease 21% · Atrial fibrillation 18% · Cancer 14% · Heart failure 10% · COPD 10% · Stroke 10% · Dementia 5%.
The office billed $479,020, Medicare allowed $248,715 and paid $184,524; for 2,634 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 587 | 2,634 | 73 | 0.91 | $479,020 | $184,524 |
| 2023 | 476 | 1,365 | 72 | 1.05 | $328,802 | $138,626 |
| 2022 | 328 | 1,054 | 72 | 1.06 | $253,154 | $105,968 |
| 2021 | 242 | 782 | 71 | 1.10 | $184,780 | $79,289 |
| 2020 | 165 | 667 | 71 | 1.12 | $148,442 | $57,063 |
| 2019 | 494 | 800 | 72 | 1.20 | $190,228 | $68,087 |
| 2018 | 507 | 942 | 71 | 1.19 | $219,790 | $83,289 |
| 2017 | 400 | 979 | 70 | 1.16 | $233,935 | $85,710 |
| 2016 | 425 | 884 | 68 | 1.29 | $185,801 | $66,936 |
| 2015 | 238 | 547 | 66 | 1.25 | $95,358 | $35,941 |
| 2014 | 255 | 455 | 67 | 1.37 | $75,966 | $25,429 |
| 2013 | 281 | 877 | 65 | 1.39 | $162,767 | $62,094 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 395 | $59,512 | $91 |
| Sleep study including heart rate, breathing, and sleep time | 185 | $45,757 | $112 |
| New patient visit (45+ min) | 250 | $28,545 | $114 |
| Long return visit (40+ min) | 12 | $2,536 | $115 |
2022: 5 services
| Return visit (30+ min) | 252 | $43,223 | $88 |
| Sleep study including heart rate, breathing, and sleep time | 107 | $38,762 | $121 |
| New patient visit (45+ min) | 177 | $20,293 | $115 |
| Short return visit (20+ min) | 11 | $771 | $70 |
| Sleep study including heart rate, breathing, airflow, and effort | 19 | $657 | $35 |
2021: 7 services
| Return visit (30+ min) | 175 | $30,943 | $95 |
| Sleep study including heart rate, breathing, and sleep time | 72 | $23,289 | $130 |
| New patient visit (45+ min) | 149 | $17,742 | $119 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 21 | $2,411 | $45 |
| Short return visit (20+ min) | 27 | $1,910 | $66 |
| Sleep study in sleep lab (6 years or older) | 11 | $1,060 | $96 |
| Sleep study including heart rate, breathing, airflow, and effort | 11 | $395 | $36 |
2020: 8 services
| New patient visit (45+ min) | 138 | $16,335 | $118 |
| Return visit (30+ min) | 97 | $15,945 | $84 |
| Sleep study including heart rate, breathing, and sleep time | 47 | $9,853 | $120 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 24 | $4,458 | $48 |
| Short return visit (20+ min) | 56 | $3,793 | $57 |
| Sleep study including heart rate, breathing, airflow, and effort | 26 | $2,186 | $81 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 12 | $1,296 | $108 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 34 | $484 | $14 |
2019: 7 services
| Return visit (30+ min) | 259 | $24,265 | $80 |
| New patient visit (45+ min) | 134 | $16,474 | $123 |
| Short return visit (20+ min) | 151 | $8,337 | $53 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 55 | $6,199 | $105 |
| Sleep study in sleep lab (6 years or older) | 64 | $5,982 | $92 |
| Sleep study including heart rate, breathing, airflow, and effort | 31 | $1,157 | $37 |
| Test to measure oxygen level in blood using ear or finger device continuously overnight | 17 | $411 | $21 |
2018: 8 services
| Return visit (30+ min) | 221 | $25,196 | $85 |
| New patient visit (45+ min) | 189 | $24,103 | $128 |
| Short return visit (20+ min) | 188 | $12,224 | $53 |
| Sleep study in sleep lab (6 years or older) | 87 | $8,606 | $99 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 61 | $6,342 | $101 |
| New patient visit (60+ min) | 29 | $4,543 | $157 |
| Sleep study including heart rate, breathing, airflow, and effort | 11 | $560 | $51 |
| Test to measure oxygen level in blood using ear or finger device continuously overnight | 19 | $440 | $20 |
2017: 7 services
| New patient visit (45+ min) | 181 | $23,202 | $128 |
| Return visit (30+ min) | 163 | $18,844 | $81 |
| Short return visit (20+ min) | 207 | $15,663 | $58 |
| Sleep study in sleep lab (6 years or older) | 104 | $10,567 | $98 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 92 | $9,995 | $99 |
| New patient visit (60+ min) | 38 | $5,882 | $155 |
| Test to measure oxygen level in blood using ear or finger device continuously overnight | 21 | $495 | $20 |
2016: 8 services
| New patient visit (45+ min) | 215 | $22,943 | $107 |
| Return visit (30+ min) | 123 | $10,317 | $70 |
| Short return visit (20+ min) | 196 | $10,295 | $38 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 96 | $9,641 | $95 |
| Sleep study in sleep lab (6 years or older) | 57 | $5,597 | $95 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 32 | $3,124 | $95 |
| New patient visit (60+ min) | 14 | $2,362 | $169 |
| Sleep study in sleep lab (6 years or older) | 14 | $1,096 | $78 |
2015: 8 services
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 84 | $8,484 | $95 |
| Short return visit (20+ min) | 114 | $7,967 | $38 |
| New patient visit (45+ min) | 69 | $6,723 | $97 |
| Return visit (30+ min) | 41 | $3,199 | $58 |
| Sleep study in sleep lab (6 years or older) | 32 | $2,961 | $93 |
| New patient visit (45+ min) | 21 | $2,281 | $109 |
| Short return visit (20+ min) | 35 | $1,804 | $46 |
| Long return visit (40+ min) | 11 | $917 | $83 |
2014: 8 services
| Short return visit (20+ min) | 166 | $9,963 | $42 |
| New patient visit (45+ min) | 60 | $6,544 | $109 |
| Return visit (30+ min) | 39 | $2,687 | $66 |
| Sleep study in sleep lab (6 years or older) | 24 | $2,215 | $92 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 17 | $1,701 | $94 |
| Return visit (30+ min) | 11 | $700 | $64 |
| Short return visit (20+ min) | 16 | $683 | $43 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 24 | $442 | $12 |
2013: 8 services
| New patient visit (45+ min) | 163 | $18,701 | $115 |
| Short return visit (20+ min) | 194 | $16,223 | $51 |
| Return visit (30+ min) | 110 | $11,158 | $74 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 78 | $7,475 | $92 |
| Sleep study in sleep lab (6 years or older) | 58 | $5,322 | $90 |
| Therapy procedure using a positive pressure ventilator | 21 | $1,252 | $43 |
| New patient visit (30+ min) | 15 | $782 | $52 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 29 | $690 | $14 |
Medicaid work
$9,030 in 2019
Medicaid paid $9,030 for 116 billed services this clinician did in 2019, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 90 | $4,782 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 14 | $2,698 |
| New patient visit (45+ min) | 12 | $1,551 |
| 2019 | 116 | 3 | 20 | $9,030 |
Drugs they prescribed that Part D paid
$192,158
Pharmacies billed $192,158 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 299) in 2024. At or below the middle of the specialty; the typical sleep medicine clinician is at 0%.
234 generic and 65 brand-name prescriptions · $192,158 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xywav | 11 | $163,399 | $14,854 |
| Belsomra | 19 | $8,255 | $434 |
| Quviviq | 13 | $6,195 | $477 |
| Dayvigo | 16 | $5,327 | $333 |
| Zolpidem Tartrate Er | 15 | $1,526 | $102 |
See all 10 drugs
| Xywav | 11 | $163,399 | $14,854 |
| Belsomra | 19 | $8,255 | $434 |
| Quviviq | 13 | $6,195 | $477 |
| Dayvigo | 16 | $5,327 | $333 |
| Zolpidem Tartrate Er | 15 | $1,526 | $102 |
| Modafinil | 24 | $1,351 | $56 |
| Zolpidem | 88 | $663 | $8 |
| Pramipexole Dihydrochloride | 27 | $251 | $9 |
| Ropinirole | 16 | $193 | $12 |
| Trazodone | 14 | $123 | $9 |
Year by year
| 2024 | 299 | 71 | 0% (0) | 22% | $192,158 |
| 2023 | 279 | 67 | 0% (0) | None | $30,207 |
| 2022 | 171 | 45 | 0% (0) | None | $14,886 |
| 2021 | 152 | 44 | None | 18% | $15,012 |
| 2020 | 51 | 25 | 0% (0) | 22% | $6,868 |
| 2019 | 131 | 31 | None | 18% | $12,373 |
| 2018 | 148 | 38 | 0% (0) | 14% | $9,970 |
| 2017 | 92 | 27 | 0% (0) | None | $3,016 |
| 2016 | 100 | 34 | None | 14% | $7,261 |
| 2015 | 119 | 27 | None | 24% | $46,830 |
| 2014 | 117 | 36 | 0% (0) | 14% | $15,054 |
| 2013 | 223 | 58 | None | 19% | $17,216 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Quviviq | 15 | $10,485 | $699 |
| Belsomra | 11 | $4,796 | $436 |
| Dayvigo | 11 | $3,774 | $343 |
| Modafinil | 22 | $2,726 | $124 |
| Dextroamphetamine-Amphetamine | 13 | $829 | $64 |
| Zolpidem | 94 | $666 | $7 |
| Pramipexole Dihydrochloride | 42 | $310 | $7 |
| Ropinirole | 11 | $135 | $12 |
2022: 6 drugs
| Dayvigo | 13 | $4,161 | $320 |
| Pramipexole Dihydrochloride | 30 | $323 | $11 |
| Dextroamphetamine-Amphetamine | 11 | $260 | $24 |
| Gabapentin | 13 | $260 | $20 |
| Trazodone | 11 | $228 | $21 |
| Zolpidem | 29 | $191 | $7 |
2021: 4 drugs
| Zolpidem | 32 | $240 | $7 |
| Eszopiclone | 11 | $86 | $8 |
| Pramipexole Dihydrochloride | 15 | $75 | $5 |
| Ropinirole | 12 | $3 | $0 |
2019: 5 drugs
| Belsomra | 15 | $7,011 | $467 |
| Azelastine | 14 | $738 | $53 |
| Fluticasone Propionate | 17 | $464 | $27 |
| Zolpidem | 24 | $204 | $9 |
| Eszopiclone | 11 | $173 | $16 |
2018: 4 drugs
| Belsomra | 19 | $6,189 | $326 |
| Eszopiclone | 21 | $1,689 | $80 |
| Pramipexole Dihydrochloride | 26 | $428 | $16 |
| Zolpidem | 23 | $151 | $7 |
2017: 3 drugs
| Pramipexole Dihydrochloride | 23 | $300 | $13 |
| Trazodone | 14 | $204 | $15 |
| Zolpidem | 13 | $86 | $7 |
2016: 3 drugs
| Pramipexole Dihydrochloride | 28 | $447 | $16 |
| Ropinirole | 14 | $188 | $13 |
| Zaleplon | 12 | $56 | $5 |
2015: 2 drugs
| Pramipexole Dihydrochloride | 20 | $1,072 | $54 |
| Ropinirole | 26 | $181 | $7 |
2014: 2 drugs
| Ropinirole | 32 | $910 | $28 |
| Fluticasone Propionate | 16 | $271 | $17 |
2013: 5 drugs
| Modafinil | 12 | $5,525 | $460 |
| Zolpidem Tartrate Er | 16 | $1,724 | $108 |
| Ropinirole | 37 | $1,485 | $40 |
| Fluticasone Propionate | 42 | $981 | $23 |
| Zolpidem | 21 | $128 | $6 |
Money from drug and device companies
$172,527 in 2025
| 2025 | 10 | 202 | $147,365 | $172,527 |
| 2024 | 8 | 172 | $122,561 | $146,569 |
| 2023 | 9 | 185 | $142,926 | $162,700 |
| 2022 | 5 | 72 | $45,694 | $53,256 |
| 2021 | 9 | 127 | $42,671 | $52,828 |
| 2020 | 4 | 57 | $25,700 | $29,617 |
| 2019 | 3 | 68 | $45,950 | $55,852 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Jazz Pharmaceuticals | Xywav | $91,039 | 83 payments
|
| Lilly USA | Zepbound | $45,117 | 50 payments
|
| Avadel CNS Pharmaceuticals | Lumryz | $25,576 | 36 payments
|
| Inspire Medical Systems | Inspire | $10,405 | 23 payments
|
| ARS Pharmaceuticals Operations | Neffy | $125 | 1 payment
|
| Fisher & Paykel Healthcare | Fisher & Paykel Healthcare | $95 | 1 payment
|
See all 202 published payments
| GlaxoSmithKline | Meals · 2025-12-29 | Arexvy | $17 |
| Avadel CNS Pharmaceuticals | Meals · 2025-12-29 | Lumryz | $22 |
| Avadel CNS Pharmaceuticals | Consulting · 2025-12-22 | Lumryz | $818 |
| Avadel CNS Pharmaceuticals | Meals · 2025-12-18 | Lumryz | $150 |
| Jazz Pharmaceuticals | Consulting · 2025-12-16 | Xywav | $6,030 |
| Jazz Pharmaceuticals | Travel · 2025-12-13 | Xywav | $945 |
| Jazz Pharmaceuticals | Travel · 2025-12-12 | Xywav | $276 |
| Jazz Pharmaceuticals | Meals · 2025-12-12 | Xywav | $146 |
| Jazz Pharmaceuticals | Paid to speak or teach · 2025-12-10 | Xywav | $4,020 |
| Avadel CNS Pharmaceuticals | Meals · 2025-12-03 | Lumryz | $24 |
| Jazz Pharmaceuticals | Meals · 2025-12-02 | Xywav | $70 |
| Jazz Pharmaceuticals | Travel · 2025-11-28 | Xywav | $683 |
| Jazz Pharmaceuticals | Paid to speak or teach · 2025-11-26 | Xywav | $5,360 |
| Lilly USA | Paid to speak or teach · 2025-11-21 | Zepbound | $900 |
| Jazz Pharmaceuticals | Meals · 2025-11-21 | Xywav | $133 |
| Inspire Medical Systems | Meals · 2025-11-17 | Inspire | $84 |
| Jazz Pharmaceuticals | Meals · 2025-11-15 | Xywav | $100 |
| Avadel CNS Pharmaceuticals | Meals · 2025-11-14 | Lumryz | $103 |
| Jazz Pharmaceuticals | Paid to speak or teach · 2025-11-13 | Xywav | $4,020 |
| Jazz Pharmaceuticals | Travel · 2025-11-13 | Xywav | $169 |
| Lilly USA | Paid to speak or teach · 2025-11-12 | Zepbound | $900 |
| Avadel CNS Pharmaceuticals | Paid to speak or teach · 2025-11-11 | Lumryz | $2,800 |
| Avadel CNS Pharmaceuticals | Meals · 2025-11-10 | Lumryz | $22 |
| EnsoData | Meals · 2025-11-08 | None | $27 |
| Lilly USA | Paid to speak or teach · 2025-11-07 | Zepbound | $900 |
| Jazz Pharmaceuticals | Travel · 2025-11-07 | Xywav | $261 |
| Avadel CNS Pharmaceuticals | Paid to speak or teach · 2025-11-06 | Lumryz | $1,600 |
| Avadel CNS Pharmaceuticals | Consulting · 2025-11-06 | Lumryz | $545 |
| Fisher & Paykel Healthcare | Meals · 2025-11-06 | Fisher & Paykel Healthcare | $95 |
| Lilly USA | Paid to speak or teach · 2025-11-05 | Zepbound | $900 |
| Resmed | Meals · 2025-11-04 | Airsense | $19 |
| Jazz Pharmaceuticals | Meals · 2025-10-29 | Xywav | $144 |
| Avadel CNS Pharmaceuticals | Meals · 2025-10-27 | Lumryz | $26 |
| GlaxoSmithKline | Meals · 2025-10-26 | Arexvy | $21 |
| Avadel CNS Pharmaceuticals | Meals · 2025-10-24 | Lumryz | $94 |
| Avadel CNS Pharmaceuticals | Travel · 2025-10-24 | Lumryz | $489 |
| Avadel CNS Pharmaceuticals | Travel · 2025-10-24 | Lumryz | $254 |
| Inspire Medical Systems | Meals · 2025-10-23 | Inspire | $128 |
| Avadel CNS Pharmaceuticals | Travel · 2025-10-20 | Lumryz | $15 |
| Avadel CNS Pharmaceuticals | Meals · 2025-10-16 | Lumryz | $20 |
| Avadel CNS Pharmaceuticals | Travel · 2025-10-09 | Lumryz | $55 |
| Jazz Pharmaceuticals | Meals · 2025-10-08 | Xywav | $15 |
| Inspire Medical Systems | Meals · 2025-10-08 | Inspire | $144 |
| Lilly USA | Paid to speak or teach · 2025-10-07 | Zepbound | $1,575 |
| Lilly USA | Paid to speak or teach · 2025-10-07 | Zepbound | $1,575 |
| Lilly USA | Paid to speak or teach · 2025-10-07 | Zepbound | $1,800 |
| Lilly USA | Paid to speak or teach · 2025-10-07 | Zepbound | $900 |
| Lilly USA | Paid to speak or teach · 2025-10-07 | Zepbound | $1,800 |
| Jazz Pharmaceuticals | Travel · 2025-10-07 | Xywav | $247 |
| Inspire Medical Systems | Consulting · 2025-10-03 | Inspire | $3,088 |
| Inspire Medical Systems | Honoraria · 2025-10-03 | Inspire | $2,000 |
| Lilly USA | Travel · 2025-10-02 | None | $759 |
| Lilly USA | Travel · 2025-10-02 | None | $159 |
| Lilly USA | Meals · 2025-10-02 | Zepbound | $104 |
| Lilly USA | Travel · 2025-10-02 | None | $159 |
| Lilly USA | Travel · 2025-10-02 | None | $977 |
| Lilly USA | Travel · 2025-10-02 | None | $409 |
| Lilly USA | Travel · 2025-10-02 | None | $546 |
| Lilly USA | Travel · 2025-10-02 | None | $558 |
| Lilly USA | Meals · 2025-10-01 | Zepbound | $103 |
| Lilly USA | Paid to speak or teach · 2025-09-30 | Zepbound | $1,800 |
| Lilly USA | Paid to speak or teach · 2025-09-30 | Zepbound | $1,125 |
| Avadel CNS Pharmaceuticals | Meals · 2025-09-29 | Lumryz | $20 |
| Lilly USA | Paid to speak or teach · 2025-09-26 | Zepbound | $900 |
| Jazz Pharmaceuticals | Meals · 2025-09-26 | Xywav | $31 |
| Inspire Medical Systems | Travel · 2025-09-26 | Inspire | $39 |
| Lilly USA | Travel · 2025-09-25 | None | $742 |
| Lilly USA | Meals · 2025-09-25 | Zepbound | $124 |
| Jazz Pharmaceuticals | Meals · 2025-09-24 | None | $43 |
| Lilly USA | Paid to speak or teach · 2025-09-23 | Zepbound | $675 |
| Lilly USA | Paid to speak or teach · 2025-09-23 | Zepbound | $1,800 |
| Lilly USA | Paid to speak or teach · 2025-09-22 | Zepbound | $900 |
| Inspire Medical Systems | Meals · 2025-09-22 | Inspire | $36 |
| Inspire Medical Systems | Travel · 2025-09-21 | Inspire | $90 |
| Inspire Medical Systems | Travel · 2025-09-20 | Inspire | $433 |
| Inspire Medical Systems | Meals · 2025-09-19 | Inspire | $32 |
| Inspire Medical Systems | Meals · 2025-09-19 | Inspire | $36 |
| Inspire Medical Systems | Meals · 2025-09-19 | Inspire | $45 |
| Inspire Medical Systems | Travel · 2025-09-19 | Inspire | $514 |
| Inspire Medical Systems | Travel · 2025-09-19 | Inspire | $217 |
| Lilly USA | Meals · 2025-09-18 | Zepbound | $16 |
| Inspire Medical Systems | Meals · 2025-09-18 | Inspire | $1 |
| Inspire Medical Systems | Meals · 2025-09-18 | Inspire | $111 |
| Lilly USA | Paid to speak or teach · 2025-09-17 | Zepbound | $900 |
| Jazz Pharmaceuticals | Meals · 2025-09-17 | Xywav | $19 |
| Jazz Pharmaceuticals | Meals · 2025-09-17 | Xywav | $2 |
| Avadel CNS Pharmaceuticals | Meals · 2025-09-07 | None | $95 |
| Jazz Pharmaceuticals | Meals · 2025-09-06 | Xywav | $104 |
| Lilly USA | Paid to speak or teach · 2025-09-05 | Zepbound | $1,800 |
| Lilly USA | Paid to speak or teach · 2025-09-05 | Zepbound | $1,125 |
| Inspire Medical Systems | Consulting · 2025-09-05 | Inspire | $2,375 |
| GlaxoSmithKline | Meals · 2025-09-04 | Arexvy | $20 |
| Avadel CNS Pharmaceuticals | Paid to speak or teach · 2025-09-03 | Lumryz | $2,800 |
| Lilly USA | Paid to speak or teach · 2025-09-02 | Zepbound | $1,125 |
| Lilly USA | Paid to speak or teach · 2025-09-02 | Zepbound | $900 |
| Lilly USA | Paid to speak or teach · 2025-09-02 | Zepbound | $1,800 |
| Lilly USA | Meals · 2025-08-29 | Zepbound | $15 |
| Lilly USA | Meals · 2025-08-27 | Zepbound | $119 |
| Lilly USA | Travel · 2025-08-27 | None | $533 |
| Lilly USA | Paid to speak or teach · 2025-08-25 | Zepbound | $900 |
| Lilly USA | Paid to speak or teach · 2025-08-22 | Zepbound | $900 |
| Lilly USA | Paid to speak or teach · 2025-08-21 | Zepbound | $900 |
| Lilly USA | Paid to speak or teach · 2025-08-21 | Zepbound | $675 |
| Lilly USA | Paid to speak or teach · 2025-08-21 | Zepbound | $1,800 |
| Avadel CNS Pharmaceuticals | Meals · 2025-08-21 | Lumryz | $121 |
| Lilly USA | Meals · 2025-08-20 | Zepbound | $95 |
| Lilly USA | Paid to speak or teach · 2025-08-18 | Zepbound | $900 |
| Avadel CNS Pharmaceuticals | Meals · 2025-08-18 | Lumryz | $23 |
| Lilly USA | Paid to speak or teach · 2025-08-14 | Zepbound | $900 |
| Lilly USA | Paid to speak or teach · 2025-08-11 | Zepbound | $900 |
| Jazz Pharmaceuticals | Paid to speak or teach · 2025-08-06 | Xywav | $4,020 |
| Jazz Pharmaceuticals | Meals · 2025-08-06 | Xywav | $15 |
| Jazz Pharmaceuticals | Education · 2025-08-05 | Xywav | $100 |
| Jazz Pharmaceuticals | Education · 2025-08-05 | Xywav | $43 |
| Harmony Biosciences | Meals · 2025-07-30 | Wakix | $19 |
| Jazz Pharmaceuticals | Paid to speak or teach · 2025-07-30 | Xywav | $5,360 |
| Jazz Pharmaceuticals | Paid to speak or teach · 2025-07-30 | Xywav | $4,020 |
| Jazz Pharmaceuticals | Travel · 2025-07-30 | Xywav | $163 |
| Jazz Pharmaceuticals | Travel · 2025-07-30 | Xywav | $43 |
| Avadel CNS Pharmaceuticals | Meals · 2025-07-25 | Lumryz | $20 |
| Jazz Pharmaceuticals | Meals · 2025-07-25 | Xywav | $144 |
| Jazz Pharmaceuticals | Travel · 2025-07-24 | Xywav | $671 |
| Jazz Pharmaceuticals | Meals · 2025-07-23 | Xywav | $122 |
| Jazz Pharmaceuticals | Meals · 2025-07-23 | Xywav | $19 |
| Lilly USA | Paid to speak or teach · 2025-07-21 | Zepbound | $675 |
| Lilly USA | Paid to speak or teach · 2025-07-21 | Zepbound | $1,800 |
| Avadel CNS Pharmaceuticals | Meals · 2025-07-21 | Lumryz | $9 |
| Jazz Pharmaceuticals | Meals · 2025-07-18 | Xywav | $129 |
| Lilly USA | Meals · 2025-07-15 | Zepbound | $100 |
| Avadel CNS Pharmaceuticals | Meals · 2025-07-14 | Lumryz | $23 |
| ARS Pharmaceuticals Operations | Meals · 2025-07-10 | Neffy | $125 |
| Jazz Pharmaceuticals | Paid to speak or teach · 2025-07-09 | Xywav | $2,010 |
| GlaxoSmithKline | Meals · 2025-07-08 | Shingrix | $14 |
| Jazz Pharmaceuticals | Meals · 2025-07-03 | Xywav | $127 |
| Jazz Pharmaceuticals | Travel · 2025-06-28 | Xywav | $389 |
| Avadel CNS Pharmaceuticals | Meals · 2025-06-25 | Lumryz | $115 |
| Avadel CNS Pharmaceuticals | Consulting · 2025-06-25 | Lumryz | $2,800 |
| Lilly USA | Paid to speak or teach · 2025-06-18 | Zepbound | $450 |
| Harmony Biosciences | Meals · 2025-06-10 | Wakix | $33 |
| Jazz Pharmaceuticals | Meals · 2025-06-09 | None | $104 |
| Avadel CNS Pharmaceuticals | Meals · 2025-06-07 | Lumryz | $119 |
| Jazz Pharmaceuticals | Meals · 2025-06-04 | Xywav | $9 |
| Jazz Pharmaceuticals | Paid to speak or teach · 2025-05-12 | Xywav | $6,030 |
| Jazz Pharmaceuticals | Paid to speak or teach · 2025-05-05 | Xywav | $4,355 |
| Jazz Pharmaceuticals | Paid to speak or teach · 2025-05-05 | Xywav | $4,355 |
| Lilly USA | Paid to speak or teach · 2025-04-29 | Zepbound | $2,700 |
| Jazz Pharmaceuticals | Meals · 2025-04-26 | Xywav | $74 |
| Jazz Pharmaceuticals | Meals · 2025-04-26 | Xywav | $49 |
| Jazz Pharmaceuticals | Meals · 2025-04-26 | Xywav | $25 |
| Jazz Pharmaceuticals | Meals · 2025-04-26 | Xywav | $25 |
| Jazz Pharmaceuticals | Meals · 2025-04-26 | Xywav | $15 |
| Jazz Pharmaceuticals | Travel · 2025-04-25 | Xywav | $463 |
| Jazz Pharmaceuticals | Travel · 2025-04-25 | Xywav | $386 |
| Jazz Pharmaceuticals | Travel · 2025-04-25 | Xywav | $335 |
| Jazz Pharmaceuticals | Meals · 2025-04-25 | Xywav | $147 |
| Jazz Pharmaceuticals | Meals · 2025-04-25 | Xywav | $120 |
| Inspire Medical Systems | Meals · 2025-04-23 | Inspire | $19 |
| Inspire Medical Systems | Meals · 2025-04-17 | Inspire | $161 |
| Jazz Pharmaceuticals | Paid to speak or teach · 2025-04-14 | Xywav | $4,020 |
| Jazz Pharmaceuticals | Meals · 2025-04-09 | Xywav | $124 |
| Jazz Pharmaceuticals | Meals · 2025-04-01 | Xywav | $1 |
| Inspire Medical Systems | Meals · 2025-03-28 | Inspire | $142 |
| Jazz Pharmaceuticals | Paid to speak or teach · 2025-03-19 | Xywav | $4,020 |
| Jazz Pharmaceuticals | Meals · 2025-03-15 | Xywav | $101 |
| Jazz Pharmaceuticals | Consulting · 2025-03-14 | Xywav | $150 |
| Avadel CNS Pharmaceuticals | Meals · 2025-03-12 | Lumryz | $44 |
| Jazz Pharmaceuticals | Meals · 2025-03-12 | Xywav | $4 |
| Inspire Medical Systems | Meals · 2025-03-08 | Inspire | $132 |
| Inspire Medical Systems | Travel · 2025-03-02 | Inspire | $95 |
| Jazz Pharmaceuticals | Travel · 2025-02-24 | Xywav | $229 |
| Jazz Pharmaceuticals | Travel · 2025-02-24 | Xywav | $87 |
| Jazz Pharmaceuticals | Paid to speak or teach · 2025-02-19 | Xywav | $4,020 |
| Jazz Pharmaceuticals | Paid to speak or teach · 2025-02-18 | Xywav | $11,390 |
| Jazz Pharmaceuticals | Paid to speak or teach · 2025-02-18 | Xywav | $5,360 |
| Jazz Pharmaceuticals | Travel · 2025-02-15 | Xywav | $714 |
| Jazz Pharmaceuticals | Travel · 2025-02-14 | Xywav | $665 |
| Jazz Pharmaceuticals | Travel · 2025-02-14 | Xywav | $194 |
| Jazz Pharmaceuticals | Meals · 2025-02-14 | Xywav | $144 |
| Jazz Pharmaceuticals | Meals · 2025-02-13 | Xywav | $116 |
| Jazz Pharmaceuticals | Travel · 2025-02-12 | Xywav | $179 |
| Jazz Pharmaceuticals | Meals · 2025-02-12 | Xywav | $122 |
| Jazz Pharmaceuticals | Travel · 2025-02-11 | Xywav | $203 |
| Jazz Pharmaceuticals | Travel · 2025-02-11 | Xywav | $203 |
| Jazz Pharmaceuticals | Travel · 2025-02-11 | Xywav | $203 |
| Jazz Pharmaceuticals | Travel · 2025-02-08 | Xywav | $204 |
| Jazz Pharmaceuticals | Travel · 2025-02-08 | Xywav | $204 |
| Jazz Pharmaceuticals | Travel · 2025-02-08 | Xywav | $204 |
| Avadel CNS Pharmaceuticals | Meals · 2025-01-31 | Lumryz | $28 |
| Avadel CNS Pharmaceuticals | Travel · 2025-01-31 | Lumryz | $810 |
| Avadel CNS Pharmaceuticals | Travel · 2025-01-31 | Lumryz | $586 |
| Avadel CNS Pharmaceuticals | Consulting · 2025-01-31 | Lumryz | $3,800 |
| Avadel CNS Pharmaceuticals | Travel · 2025-01-30 | Lumryz | $432 |
| Avadel CNS Pharmaceuticals | Consulting · 2025-01-30 | Lumryz | $3,800 |
| Avadel CNS Pharmaceuticals | Meals · 2025-01-30 | Lumryz | $94 |
| Inspire Medical Systems | Travel · 2025-01-24 | Inspire | $482 |
| Jazz Pharmaceuticals | Travel · 2025-01-18 | Xywav | $466 |
| Jazz Pharmaceuticals | Travel · 2025-01-18 | Xywav | $466 |
| Jazz Pharmaceuticals | Travel · 2025-01-18 | Xywav | $466 |
| Jazz Pharmaceuticals | Travel · 2025-01-18 | Xywav | $33 |
| Jazz Pharmaceuticals | Travel · 2025-01-18 | Xywav | $33 |
| Jazz Pharmaceuticals | Travel · 2025-01-18 | Xywav | $33 |
| Avadel CNS Pharmaceuticals | Paid to speak or teach · 2025-01-14 | Lumryz | $2,800 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $146,569
| Jazz Pharmaceuticals | Xywav | $92,189 | 93 payments
|
| Idorsia Pharmaceuticals US | Quviviq | $30,478 | 34 payments
|
| Avadel CNS Pharmaceuticals | Lumryz | $18,940 | 24 payments
|
| Inspire Medical Systems | Inspire | $4,652 | 13 payments
|
| Harmony Biosciences | Wakix | $156 | 3 payments
|
| Axsome Therapeutics | Sunosi | $81 | 2 payments
|
| Resmed | Airsense | $39 | 2 payments
|
| SomnoMed | None | $34 | 1 payment
|
2023: $162,700
| Jazz Pharmaceuticals | Xywav | $98,284 | 104 payments
|
| Idorsia Pharmaceuticals US | Quviviq | $32,869 | 27 payments
|
| Axsome Therapeutics | Sunosi | $13,473 | 19 payments
|
| Inspire Medical Systems | Inspire | $12,446 | 22 payments
|
| Harmony Biosciences | Wakix | $5,456 | 8 payments
|
| ZOLL Respicardia | Remede System | $80 | 2 payments
|
| Medtronic | Linq II | $39 | 1 payment
|
| Abbott Laboratories | Aveir | $32 | 1 payment
|
| Avadel CNS Pharmaceuticals | Lumryz | $21 | 1 payment
|
2022: $53,256
| Jazz Pharmaceuticals | Xywav | $28,625 | 51 payments
|
| Inspire Medical Systems | Inspire Upper Airway Stimulation System | $14,048 | 3 payments
|
| Harmony Biosciences | Wakix | $4,903 | 6 payments
|
| Idorsia Pharmaceuticals US | Quviviq | $4,155 | 6 payments
|
| ZOLL Respicardia | Remede System | $1,526 | 1 payment
|
2021: $52,828
| Jazz Pharmaceuticals | Sunosi | $40,867 | 78 payments
|
| Inspire Medical Systems | Inspire Upper Airway Stimulation System | $7,476 | 6 payments
|
| Harmony Biosciences | Wakix | $4,057 | 10 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $195 | 2 payments
|
| Eisai | Dayvigo | $120 | 8 payments
|
| Itamar Medical | Watchpat | $46 | 1 payment
|
| Arbor Pharmaceuticals | Horizant | $25 | 2 payments
|
| Vapotherm | Vapotherm | $22 | 1 payment
|
| Resmed | Airsense | $20 | 1 payment
|
2020: $29,617
| Jazz Pharmaceuticals | Sunosi | $29,195 | 48 payments
|
| Harmony Biosciences | Wakix | $309 | 4 payments
|
| Eisai | Dayvigo | $78 | 4 payments
|
| Novo Nordisk | None | $34 | 1 payment
|
2019: $55,852
| Jazz Pharmaceuticals | Sunosi | $55,633 | 64 payments
|
| Novo Nordisk | Saxenda | $204 | 3 payments
|
| Philips Electronics North America | Trilogy 100 | $15 | 1 payment
|
Professional record
- NPI
- 1992965156
- Licence
- CA A115489, IL 036140333, TX R7027California A115489: Current · expires 2028-08-31Illinois 036140333: ActiveTexas R7027: Active
- Group
- Jig International LLC · Coryell County Memorial Hospital Authority
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- IL 036140333
- Taxonomy
- Federal specialty code 2084S0012X (2084S0012X); Federal specialty code 207QS1201X (207QS1201X); Federal specialty code 207RS0012X (207RS0012X); Federal specialty code 2083B0002X (2083B0002X)
- Mailing address
- 4645 Avon Ln Ste 340, Frisco, TX, 75033
- NPI first listed
- 2008-06-11
- NPI last updated
- 2024-04-30
- NPI record certified
- 2024-04-30
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Palo Alto, CA, 94304
This office lists an electronic records connection.